1. Evidence is presented that exposure of epididymal fat-pads from fed rats to insulin leads to a marked diminution in the Km for phosphoenolpyruvate of pyruvate kinase. Effects of insulin may be readily demonstrated in experiments both in vivo and in vitro and are not secondary to the activation by the hormone of glucose transport. No effect of insulin is apparent in tissues from 48 h-starved animals. 2. The mechanism of the effect of insulin on pyruvate kinase was not established. The observed changes in Km do not appear to be the result of alterations in the amounts of bound effectors such as fructose 1,6-bisphosphate and alanine. Rather, as the effect persists in incubated extracts, it appears that a change in the degree ofphosphorylation or some other covalent modification of the enzyme may be involved.
At least three different isoenzymes of pyruvate kinase (EC 2.7.1.40) exist in animal tissues (Imamura & Tanaka, 1972; Harada et al., 1978; Engstrom, 1978) . The M1-type isoenzyme is found in muscle and brain, whereas the L-type isoenzyme is the major type present in liver and is also found as a minor component in kidney. The pyruvate kinase present in most tissues, including adipose tissue, appears to be the third isoenzyme or group of isoenzymes, which have been designated variously by different laboratories as M2, K or A types (M2 is used in the present paper).
The activity of the L-type isoenzyme is regulated by a number of effectors, including fructose 1,6-bisphosphate (activator) and alanine (inhibitor).
These effectors alter the apparent Km towards phosphoenolpyruvate with little or no effect on the maximum activity (Seubert & Schoner, 1971) . The apparent Km for phosphoenolpyruvate of the L-type isoenzyme is also markedly increased by phosphorylation brought about by cyclic AMP-dependent protein kinase (Ljungstrom et al., 1974; Engstrom, 1978) . Changes in phosphorylation have been shown to occur in intact liver preparations associated with increased tissue concentrations of cyclic AMP, for example in the presence of glucagon (Feliu' et al., 1977; Ljungstrom & Ekman, 1977; Riou et al., 1978) . The apparent Km for phosphoenolpyruvate of the M2-type isoenzyme from a number of cell types may also be increased and decreased by fructose 1,6-bisphosphate and alanine respectively under appropriate conditions (Pogson, 1968a,b; Imamura & Tanaka, 1972) . Early studies by Pogson (1968a,b) * Present address: Biological Laboratory, University of Kent, Canterbury, Kent CT2 7NJ, U.K.
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indicated that the adipose-tissue enzyme may exist in interconvertible forms. One, present in tissue extracts prepared with buffers containing EDTA, exhibited sigmoid steady-state kinetics with phosphoenolpyruvate and a high Ki; the other form predominated in tissues extracted in the absence of EDTA and showed hyperbolic kinetics with phosphoenolpyruvate and a much lower Km. The high-Km form could be converted into the low-Km form by incubation of tissue extracts with fructose 1,6-bisphosphate. Pogson (1968a) presented evidence that the two forms had different overall charge and apparent molecular weight. Subsequently similar properties have been found with M2-type enzymes from a number of other sources (Ibsen & Trippet, 1972; Walker & Potter, 1973; Van Berkel et al., 1974; Feliu, 1975; Eigenbrodt & Schoner, 1977a; Nishimura et al., 1978) . It has been suggested that the two forms represent the enzyme with and without bound fructose 1,6-bisphosphate, since dissociation of fructose 1,6-bisphosphate has been reported to be very slow (Irving et al., 1972; Seubert & Schoner, 1971) . More recent studies indicate that the low-Km form is a tetramer (mol.wt. about 200000) and the high-Km form is a dimer (mol.wt. about 100000) (Ibsen & Trippet, 1972; Sparmann et al., 1973; Eigenbrodt & Schoner, 1977b; Nishimura et al., 1978) . The M2-type isoenzymes are not substrates for the cyclic AMP-dependent protein kinase, but phosphorylation by a cyclic AMP-independent protein kinase leading to inhibition of enzymic activity has been demonstrated with the M2-type isoenzyme from chicken liver (Berglund et al., 1977; Eigenbrodt & Schoner, 1977b) .
In this paper, we present evidence that exposure to insulin in vitro or in vivo of rat epididymal adipose tissue from fed, but not from starved, animals leads to a substantial decrease in the Km of pyruvate kinase. The effect of insulin on adipose-tissue pyruvate kinase does not appear to be the result of changes in the amounts of bound effectors such as fructose 1,6-bisphosphate and alanine. Rather, our results are compatible with insulin causing some change in the extent of phosphorylation or other stable covalent modification of the enzyme.
Experimental Animals
Epididymal fat-pads were obtained from male Wistar albino rats (170-200g) . Unless otherwise stated the rats were fed ad libitum with stock laboratory diet (modified 41B; Oxoid, Basingstoke, Hants., U.K.). Before injections of glucose or antiinsulin serum the rats were anaesthetized with Sagatal (pentobarbital; 1ml/kg) and the rats remained under anaesthesia until the pads were removed and immediately frozen with liquid N2.
Materials
All biochemicals and enzymes, including phosphoenolpyruvate (potassium salt) and pig heart lactate dehydrogenase, were from Boehringer Corp. (London), Lewes, East Sussex, U.K. Chemicals were of the purest grade available from British Drug Houses, Poole, Dorset, U.K. Insulin was obtained from Sigma (London) Chemical Co., Poole, Dorset, U.K. Anti-insulin serum prepared by the method of Robinson & Wright (1961) was the kind gift of Dr. A. S. Cole of this Department. The sera bound approx. 5.ug of '251-labelled bovine insulin/ml at 4°C.
Incubation and extraction of epididymalfat-pads
The pads were preincubated with shaking for 30min at 37°C in bicarbonate-buffered medium (Krebs & Henseleit, 1932) Assays were essentially linear with time and extract volume over the range used. Particular care was taken that the pH of the buffer was adjusted to pH7.5 at 30°C after all additions (except extract and phosphoenolpyruvate) had been made.
Gelfiltration ofpyruvate kinase
Extracts were centrifuged at lOOOOOg for 1 h. A sample (2ml) of the supernatant was applied to a column (1Ocm x 18mm) of Sepharose CL-6B which had previously been equilibrated with the extraction buffer with or without fructose 1,6-bisphosphate as appropriate. The column was eluted with the same buffer at about 20ml/h at 4°C. Pig heart lactate dehydrogenase (mol.wt. 160000) was added to the sample applied to the column to act as an internal reference compound.
Expression ofresults
A unit of enzyme activity is taken as that amount Fig. 1 were obtained with extracts prepared at pH 7.5. In contrast, the pH at which the assay of pyruvate kinase was conducted was found to be of crucial importance. If activity was assayed at pH6.5, no effects of insulin or of incubation in the presence or absence of fructose 1 ,6-bisphosphate were apparent. At pH 7.0, the changes were appreciably less than those at pH 7.5.
The changes in sensitivity to phosphoenolpyruvate concentrations of pyruvate kinase activity in the three types of extract used in the present study are illustrated in more detail in Fig. 2 . The kinetic constants derived from the data of this typical experiment are given in Table 1 . As reported by others for M2-type isoenzymes of pyruvate kinase from adipose tissue and other sources (Pogson, 1968b; Imamura & Tanaka, 1972 In initial extracts of control tissues the value was about 300upM, which was diminished to about 200pM in initial extracts of insulin-treated tissues. Incubation of extracts with fructose 1,6-bisphosphate lowered the Km to about 100pM, and this value was the same for extracts from both insulin-treated and control tissues. Incubation in the absence of fructose 1,6-bisphosphate followed by storage at 0°C greatly increased the K., but the effect of insulin remained.
In a separate but similar experiment to the one reported in Fig. 2 As found previously with the adipose-tissue enzyme (Pogson, 1968b) and also with the M2-type isoenzyme from platelets (Nishimura et al., 1978) , we observed little or no activation over 5-10min if fructose 1,6-bisphosphate was added directly to the assay mixture. In contrast, incubation ofthe undiluted original extracts with fructose 1,6-bisphosphate appeared to result quickly in complete conversion of the enzyme into its tetrameric form (Eigenbrodt & Schoner, 1977b; Nishimura et al., 1978 (Schulz et al., 1975) . The apparent facilitation of this process by a short preincubation of the extracts at 30°C in the present studies may be because the period at 30°C allows dissociation and loss of bound fructose 1,6-bisphosphate. In any case, when such extracts were applied to the Sepharose CL-6B column equilibrated with fructose 1,6-bisphosphate-free buffer, the activity of pyruvate kinase was eluted as a single peak with a molecular weight (about 100000) which corresponds to the dimer. The same pattern of elution of pyruvate kinase activity was observed with extracts from both control and insulin-treated tissues.
Alanine was found to be a potent and immediate inhibitor of adipose-tissue pyruvate kinase activity when added to the assay mixture, as reported earlier for other M2-type isoenzymes (Imamura & Tanaka, 1972) . Effects of alanine on the activity of pyruvate kinase in extracts from control and insulin-treated tissues are compared in Fig. 3 under two different sets of conditions, where in the absence of alanine there is no effect of insulin. The two situations are: assay of activity in extracts not treated with fructose 1,6-bisphosphate at high saturating phosphoenolpyruvate concentrations (Fig. 3a) and assay of activity in fructose 1,6-bisphosphate-treated extracts at low phosphoenolpyruvate concentrations (Fig.  3b) . It is evident that, in the presence of increasing concentrations of alanine, the effect of insulin becomes clearly manifested again in both cases. Thus it is possible to demonstrate an effect of insulin after additions of substantial amounts of phosphoenolpyruvate, fructose 1,6-bisphosphate and alanine to the extracted enzyme. It is therefore very unlikely that the differences in kinetic behaviour observed after exposure of tissue to insulin are due to varying amounts of effector or substrate remaining bound to the enzyme after extraction. The results of Fig.  3 also suggest that insulin treatment results in the conversion of pyruvate kinase into a form that, particularly at high phosphoenolpyruvate concentrations, is much less sensitive to inhibition by alanine.
Effects of insulin on pyruvate kinase activity in epididymalfat-pads from fed and starved rats Table 2 shows values of the maximum activity of pyruvate kinase (measured at 4mM-phosphoenolpyruvate) together with values of the activity measured at 0.1 mM-phosphoenolpyruvate (expressed as a percentage of the maximum activity).
In the experiments in vitro (Table 2a) Concn. of L-alanine (mM) Fig. 3 . Effects of alanine ont pyruvate kinase activity in extracts of rat epididymal fat-pads which had been incubated in the absence (0) or presence (a) of insulin Incubation conditions were as described in the legend to Fig. 1. (a) Pyruvate kinase activity assayed in extract (ii) as described in Fig. 2 with 4mM-phosphoenolpyruvate and various concentrations of alanine. (b) Pyruvate kinase activity assayed in extract (iii) as described in Fig. 2 1979 from fed rats were entirely consistent with the studies reported in Figs. 1 and 2 , namely, insulin did not affect the maximum activity of pyruvate kinase, but the activity measured at 0.1mM-phosphoenolpyruvate in extracts (i) and (ii) was significantly increased; the effect of insulin was no longer apparent if extracts were incubated with fructose 1,6-bisphosphate (extract iii). The effects of starvation for 48 h on the activity of pyruvate kinase in fat-pads was also investigated. In preliminary experiments it was evident that the kinetic properties of pyruvate kinase in extracts of pads from starved animals incubated for 30min with glucose in the absence of insulin were very similar to those obtained for tissue from fed animals incubated under the same conditions. However, in marked contrast with pads from fed animals, incubation with insulin had little or no effect on pyruvate kinase activity in pads from starved rats (Table 2a ).
In the experiments in vivo (Table 2b) , the concentration of circulating insulin in anaesthetized rats was manipulated by injection of either anti-insulin serum or glucose 10 or 20min before removal and freezeclamping of the fat-pads. We have used this technique previously to demonstrate the effects of insulin in vivo on fatty acid synthesis and the activities of pyruvate dehydrogenase and acetyl-CoA carboxylase in epididymal fat-pads and interscapular brown adipose tissue (Stansbie et al., 1976; McCormack & Denton, 1977) . The technique of injecting glucose has the advantage of ensuring high circulating insulin concentrations in the physiological range without the hypoglycaemia that would follow the injection of insulin itself. Injection of anti-insulin serum causes a marked rise in blood glucose within 15 min, from 6-9 mM in anaesthetized control animals to 12-20 mM; these elevated values are then maintained for at least a further 60min (D. Stansbie, G. L. Evans & R. M. Denton, unpublished work) . The activity profiles of pyruvate kinase found in extracts of fat-pads of rats previously treated with anti-insulin serum or glucose for 10 or 20min were very similar to those found in vitro in pads incubated with glucose in the absence or presence of insulin respectively (Table 2b) . When anti-insulin serum and glucose were injected into the same animal, the results were not significantly different from those found after injection of anti-insulin serum alone; this supports the view that the changes in activity of pyruvate kinase observed after injection with either glucose or anti-insulin serum separately are related to changes in the concentration of circulating insulin rather than, for example, changes in the concentration of blood glucose.
Effects of substrate and adrenaline on the activity of pyruvate kinase in rat epididymalfat-pads Incubation of the pads in the absence of any added substrate appears to have little or no effect on the activation of pyruvate kinase activity by insulin (Table 3 ). This indicates that the effect of insulin on the enzyme is not secondary to the increased rates of glucose transport and metabolism that occur in the presence of the hormone. This view is supported by the observation that insulin has a similar effect on pyruvate kinase activity when glucose is replaced by fructose (Table 3 ). Fructose appears to enter fatcells by a separate carrier system from that involved in glucose transport, and its uptake into fat-cells is increased by insulin to a much smaller extent than the uptake of glucose (Froesch, 1965; Coore et al., 1971) . Table 3 . Effects ofincubation ofrat epididymal adipose tissue with or without insulin in the presence ofno substrate, fructose, glucose and adrenaline on the activity ofpyruvate kinase Pads from fed rats were preincubated in bicarbonate-buffered medium containing glucose (11 mM), fructose (11 mM) or no substrate as appropriate for 30min and then transferred to fresh medium of similar composition plus insulin (0.5jug/ml) and/or adrenaline bitartrate (2uig/ml) as indicated and incubated for a further 30min. Pads were then frozen in liquid N2 and pyruvate kinase activity was assayed in extracts prepared as described for extract (ii) in the legend of Fig. 2 Adrenaline was found to have little or no effect on the basal pyruvate kinase activity when added to the medium of pads incubated in the presence of glucose. However, adrenaline does reverse the activating effects of insulin (Table 3) .
General conclusions
The results of this paper appear to represent the first demonstration of the short-term regulation of pyruvate kinase activity in a tissue other than the liver. Changes in the properties of pyruvate kinase of adipose tissue from fed rats have been shown to occur in vitro with insulin, and very similar changes are found in vivo within a few minutes of altering the concentration of circulating insulin with injections of anti-insulin serum or glucose.
The mechanism of the effect of insulin has not been established. It appears unlikely from the results of the present studies on whole tissue extracts that the changes in activity are related to differing amounts of effectors such as fructose 1,6-bisphosphate remaining bound to the enzyme. The persistence of the effect in extracts incubated at 30°C and/or stored at 0°C suggests that a stable covalent modification is involved, such as a decrease in the ratio of phosphorylated to dephosphorylated forms after exposure of adipose tissue to insulin.
We have not been able to obtain unequivocal evidence that the adipose-tissue enzyme is regulated by a phosphorylation-dephosphorylation cycle to date. This is largely because the enzyme appears to be rather unstable in extracts prepared without EDTA. The changes in apparent Km for phosphoenolpyruvate observed in the present studies with insulin are rather similar to those which have been shown by others to be associated with dephosphorylation of the L-type isoenzyme (Engstrom, 1978) . The changes in the activity of the M2-type isoenzyme from chicken liver which have been reported to occur on phosphorylation appear to be largely on the maximum activity of the enzyme rather than the Km for phosphoenolpyruvate (Eigenbrodt & Schoner, 1977b) .
The changes in pyruvate kinase activity at low phosphoenolpyruvate concentrations with insulin and adrenaline parallel closely not only the changes in rates of fatty acid synthesis from glucose in epididymal fat-pads but also the changes that we have previously found in the proportion of pyruvate dehydrogenase and acetyl-CoA carboxylase in their respective active forms (for reviews see Denton et al., 1977 see Denton et al., , 1978 . There are thus at least three enzymes in the pathway of fatty acid synthesis from glucose which are activated by insulin. It is not appropriate here to discuss at length the mechanisms that may be involved. However, it should be emphasized that the mechanisms are likely to be closely linked. All three activations are independent of glucose transport and are largely reversed by adrenaline (Denton et al., , 1978 . Pyruvate kinase certainly offers a further intracellular target of insulin action which clearly merits further investigation as a possible means of gaining insights into the general problem of the mechanism of insulin action. It would appear to have some advantages for this purpose over other enzymes regulated by insulin: these include the ease of assay and the relatively high activity of the enzyme in most cells. The lack of any insulin effect on the enzyme in adipose tissue from starved animals suggests that the enzyme may prove especially useful as a convenient indicator of insulin 'sensitivity' of fat-and other cells.
